267 related articles for article (PubMed ID: 21261683)
21. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
[TBL] [Abstract][Full Text] [Related]
22. Natural killer/T-cell nasal-type lymphoma: unusual primary spinal tumor.
Yang C; Ma J; Yang X; Jia L; Liu H; Xiao J
Spine (Phila Pa 1976); 2008 Nov; 33(24):E929-32. PubMed ID: 19011534
[TBL] [Abstract][Full Text] [Related]
23. [Molecular pathogenesis of peripheral T cell lymphoma (2): extranodal NK/T cell lymphoma, nasal type, adult T cell leukemia/lymphoma and enteropathy associated T cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Nov; 31(11):1023-33. PubMed ID: 26576610
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
[TBL] [Abstract][Full Text] [Related]
25. Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).
Dearden CE; Johnson R; Pettengell R; Devereux S; Cwynarski K; Whittaker S; McMillan A;
Br J Haematol; 2011 May; 153(4):451-85. PubMed ID: 21480860
[TBL] [Abstract][Full Text] [Related]
26. Angiocentric lymphomas (lymphomatous vasculitis).
Natkunam Y; Warnke RA
Semin Diagn Pathol; 2001 Feb; 18(1):67-77. PubMed ID: 11296995
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
29. [Splenic T-cell and NK-cell lymphomas: a clinicopathologic and immunophenotypic analysis of 9 cases].
Li Z; Liu WP; Tang Y; Jiang LL; Zhang WY; Bi CF; Li GD
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):217-22. PubMed ID: 17877195
[TBL] [Abstract][Full Text] [Related]
30. The microenvironment in T-cell lymphomas: emerging themes.
Gaulard P; de Leval L
Semin Cancer Biol; 2014 Feb; 24():49-60. PubMed ID: 24316493
[TBL] [Abstract][Full Text] [Related]
31. Tricky and terrible T-cell tumors: these are thrilling times for testing: molecular pathology of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Hematology Am Soc Hematol Educ Program; 2011; 2011():336-43. PubMed ID: 22160055
[TBL] [Abstract][Full Text] [Related]
32. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.
Rodriguez-Abreu D; Filho VB; Zucca E
Hematol Oncol; 2008 Mar; 26(1):8-20. PubMed ID: 18050364
[TBL] [Abstract][Full Text] [Related]
33. Extranodal peripheral T-cell and NK-cell neoplasms.
Jaffe ES; Krenacs L; Kumar S; Kingma DW; Raffeld M
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S46-55. PubMed ID: 9894469
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
35. Pathobiology of T-cell and NK-cell lymphomas.
Bajor-Dattilo EB; Pittaluga S; Jaffe ES
Best Pract Res Clin Haematol; 2013 Mar; 26(1):75-87. PubMed ID: 23768642
[TBL] [Abstract][Full Text] [Related]
36. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
38. Peripheral T-cell lymphoma gene expression profiles.
Martinez-Delgado B
Hematol Oncol; 2006 Sep; 24(3):113-9. PubMed ID: 16676369
[TBL] [Abstract][Full Text] [Related]
39. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
[TBL] [Abstract][Full Text] [Related]
40. Pathobiology of peripheral T-cell lymphomas.
Jaffe ES
Hematology Am Soc Hematol Educ Program; 2006; ():317-22. PubMed ID: 17124078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]